Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 2
1961 1
1962 1
1969 1
1975 1
1976 1
1979 2
1980 1
1981 1
1983 1
1984 3
1985 4
1986 1
1987 1
1988 7
1989 6
1990 2
1991 5
1992 3
1993 3
1994 3
1995 8
1996 3
1998 9
2000 8
2001 1
2002 7
2003 3
2004 10
2005 4
2006 15
2007 21
2008 14
2009 32
2010 28
2011 28
2012 43
2013 56
2014 40
2015 47
2016 53
2017 57
2018 71
2019 69
2020 91
2021 150
2022 150
2023 213
2024 90

Text availability

Article attribute

Article type

Publication date

Search Results

1,206 results

Results by year

Filters applied: . Clear all
Page 1
Mechanisms of Resistance to Antibody-Drug Conjugates.
Khoury R, Saleh K, Khalife N, Saleh M, Chahine C, Ibrahim R, Lecesne A. Khoury R, et al. Among authors: ibrahim r. Int J Mol Sci. 2023 Jun 2;24(11):9674. doi: 10.3390/ijms24119674. Int J Mol Sci. 2023. PMID: 37298631 Free PMC article. Review.
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma.
Behary J, Amorim N, Jiang XT, Raposo A, Gong L, McGovern E, Ibrahim R, Chu F, Stephens C, Jebeili H, Fragomeli V, Koay YC, Jackson M, O'Sullivan J, Weltman M, McCaughan G, El-Omar E, Zekry A. Behary J, et al. Among authors: ibrahim r. Nat Commun. 2021 Jan 8;12(1):187. doi: 10.1038/s41467-020-20422-7. Nat Commun. 2021. PMID: 33420074 Free PMC article.
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial.
Padrón LJ, Maurer DM, O'Hara MH, O'Reilly EM, Wolff RA, Wainberg ZA, Ko AH, Fisher G, Rahma O, Lyman JP, Cabanski CR, Yu JX, Pfeiffer SM, Spasic M, Xu J, Gherardini PF, Karakunnel J, Mick R, Alanio C, Byrne KT, Hollmann TJ, Moore JS, Jones DD, Tognetti M, Chen RO, Yang X, Salvador L, Wherry EJ, Dugan U, O'Donnell-Tormey J, Butterfield LH, Hubbard-Lucey VM, Ibrahim R, Fairchild J, Bucktrout S, LaVallee TM, Vonderheide RH. Padrón LJ, et al. Among authors: ibrahim r. Nat Med. 2022 Jun;28(6):1167-1177. doi: 10.1038/s41591-022-01829-9. Epub 2022 Jun 3. Nat Med. 2022. PMID: 35662283 Free PMC article. Clinical Trial.
Canadian Spontaneous Coronary Artery Dissection Cohort Study: 3-Year Outcomes.
Saw J, Starovoytov A, Aymong E, Inohara T, Alfadhel M, McAlister C, Samuel R, Grewal T, Parolis JA, Sheth T, So D, Minhas K, Brass N, Lavoie A, Bishop H, Lavi S, Pearce C, Renner S, Madan M, Welsh RC, McGrath BM, Vijayaraghavan R, Har B, Ibrahim R, Chaudhary P, Ganesh SK, Graham J, Matteau A, Martucci G, Ko DT, Humphries K, Mancini GJ. Saw J, et al. Among authors: ibrahim r. J Am Coll Cardiol. 2022 Oct 25;80(17):1585-1597. doi: 10.1016/j.jacc.2022.08.759. J Am Coll Cardiol. 2022. PMID: 36265953 Free article.
Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2.
Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, Andrew A, Young K, Ma T, Hoh R, Anglin K, Huang B, Argueta U, Lopez M, Valdivieso D, Asare K, Deveau TM, Munter SE, Ibrahim R, Ständker L, Lu S, Goldberg SA, Lee SA, Lynch KL, Kelly JD, Martin JN, Münch J, Deeks SG, Henrich TJ, Roan NR. Yin K, et al. Among authors: ibrahim r. bioRxiv [Preprint]. 2023 Aug 4:2023.02.09.527892. doi: 10.1101/2023.02.09.527892. bioRxiv. 2023. PMID: 36798286 Free PMC article. Updated. Preprint.
Canadian Cardiovascular Society 2022 Guidelines for Cardiovascular Interventions in Adults With Congenital Heart Disease.
Marelli A, Beauchesne L, Colman J, Ducas R, Grewal J, Keir M, Khairy P, Oechslin E, Therrien J, Vonder Muhll IF, Wald RM, Silversides C, Barron DJ, Benson L, Bernier PL, Horlick E, Ibrahim R, Martucci G, Nair K, Poirier NC, Ross HJ, Baumgartner H, Daniels CJ, Gurvitz M, Roos-Hesselink JW, Kovacs AH, McLeod CJ, Mulder BJ, Warnes CA, Webb GD. Marelli A, et al. Among authors: ibrahim r. Can J Cardiol. 2022 Jul;38(7):862-896. doi: 10.1016/j.cjca.2022.03.021. Epub 2022 Apr 20. Can J Cardiol. 2022. PMID: 35460862
KRASG12C mutation in metastatic colorectal cancer: a new target.
Ibrahim R, Saleh K, Chahine C, Khoury R, Khalife N, Lecesne A. Ibrahim R, et al. Future Oncol. 2023 Aug;19(24):1641-1643. doi: 10.2217/fon-2023-0223. Epub 2023 Aug 21. Future Oncol. 2023. PMID: 37602398 No abstract available.
Editorial: Aging Research and Practices in Malaysia.
Ahmad SA, Tan PM, Singh DKA, Ibrahim R, Teh PL, Hamid TA. Ahmad SA, et al. Among authors: ibrahim r. Front Public Health. 2022 Jun 30;10:948822. doi: 10.3389/fpubh.2022.948822. eCollection 2022. Front Public Health. 2022. PMID: 35844857 Free PMC article. No abstract available.
Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma.
Khoury R, Khalife N, Ibrahim R, Saleh K. Khoury R, et al. Among authors: ibrahim r. Hepatobiliary Surg Nutr. 2023 Dec 1;12(6):923-926. doi: 10.21037/hbsn-23-476. Epub 2023 Nov 15. Hepatobiliary Surg Nutr. 2023. PMID: 38115933 Free PMC article. No abstract available.
Trends in antimicrobial resistance in Malaysia.
Naeemmudeen NM, Mohd Ghazali NAN, Bahari H, Ibrahim R, Samsudin AD, Jasni AS. Naeemmudeen NM, et al. Among authors: ibrahim r. Med J Malaysia. 2021 Sep;76(5):698-705. Med J Malaysia. 2021. PMID: 34508377 Free article. Review.
1,206 results